GlaxoSmithKline Pharmaceuticals Ltd (GSK) has launched its technical development centre in India. This is GSK's new state of art technical development centre in India. It is intended to cater to the international market for pharmaceutical evaluation by utilizing the expertise of highly skilled Indian scientists and engineers, with the latest computerized facilities, conforming to international standards.
The centre was inaugurated by Jean-Paul Reynaud, SVP, regional pharma supply in the presence of Kay-Yong Tan, VP, India and China sourcing supply and Dr Ashoke Banerjee, executive director, GSK India.
Speaking on the occasion of the inauguration, Jean-Paul Reynaud recognized Indian talent and competencies and said, "At the end of the day what is going to make the difference is people." Talking about the new facility and the way forward, he added, "The purpose for this facility is to serve our customers".
In the new centre company will develop knowledge in the form of process and product understanding by utilizing design of Experiments, chemometrics and other lean sigma tools. The new centre will support the development of solid, liquid and semisolid dosage forms along with analytical and packaging enhancements. This centre will cater to the needs of global GSK manufacturing units in order to provide better service to the ultimate customer by improving the quality of product and ensuring security of supply.